title: Survivin gene expression in endometriosis.
abstract: Survivin is a novel inhibitor of apoptosis and is expressed during fetal development and in cancer tissues, but its expression has not been reported in normal adult tissues or benign diseases. We investigated survivin gene and protein expression in a tumor-like benign disease, endometriosis, and correlated them with apoptosis and invasive phenotype of endometriotic tissues. Gene expression levels of survivin, matrix metalloproteinase (MMP)-2, MMP-9, and membrane type 1 (MT1)-MMP in 63 pigmented or nonpigmented endometriotic tissues surgically obtained from 35 women with endometriosis were compared with those in normal eutopic endometrium obtained from 12 women without endometriosis. Survivin, MMP-2, MMP-9, and MT1-MMP mRNA expression levels in clinically aggressive pigmented lesions were significantly higher than those in normal eutopic endometrium, and survivin gene expression in pigmented lesions was also higher than that in nonpigmented lesions (P < 0.05). There was a close correlation between survivin and MMP-2, MMP-9, or MT1-MMP gene expression levels in 63 endometriotic tissues examined (P < 0.01). Apoptotic cells detected by the dUTP nick-end labeling were rare in 11 ovarian endometriotic tissues, which showed positive immunohistochemical expression for survivin and MMPs. Our findings suggest that up-regulation of survivin and MMPs may cooperatively contribute to survival and invasion of endometriosis.
authors.affiliation: Department of Obstetrics and Gynecology, Osaka Medical College, 2-7 Daigakumachi, Takatsuki, Osaka 569-8686, Japan. gyn017@poh.osaka-med.ac.jp
authors.forename: Masatsugu
authors.initials: M
authors.lastname: Ueda
authors.forename: Yoshiki
authors.initials: Y
authors.lastname: Yamashita
authors.forename: Mikio
authors.initials: M
authors.lastname: Takehara
authors.forename: Yoshito
authors.initials: Y
authors.lastname: Terai
authors.forename: Koji
authors.initials: K
authors.lastname: Kumagai
authors.forename: Ken
authors.initials: K
authors.lastname: Ueki
authors.forename: Koji
authors.initials: K
authors.lastname: Kanda
authors.forename: Hiroyuki
authors.initials: H
authors.lastname: Yamaguchi
authors.forename: Daisuke
authors.initials: D
authors.lastname: Akise
authors.forename: Yao-Ching
authors.initials: YC
authors.lastname: Hung
authors.forename: Minoru
authors.initials: M
authors.lastname: Ueki
mesh_terms: D000328:Adult; D017209:Apoptosis; D002868:Chromosomal Proteins, Non-Histone / Q000235:genetics* / Q000378:metabolism; D004715:Endometriosis / Q000235:genetics* / Q000503:physiopathology; D005260:Female; D015870:Gene Expression; D006801:Humans; D051034:Inhibitor of Apoptosis Proteins; D020778:Matrix Metalloproteinase 2 / Q000235:genetics; D020780:Matrix Metalloproteinase 9 / Q000235:genetics; D053504:Matrix Metalloproteinases, Membrane-Associated; D008666:Metalloendopeptidases / Q000235:genetics; D008869:Microtubule-Associated Proteins; D009363:Neoplasm Proteins; D010049:Ovarian Diseases / Q000503:physiopathology; D010641:Phenotype; D012333:RNA, Messenger / Q000378:metabolism; D012016:Reference Values; D000077022:Survivin
chemical_list: C107489:BIRC5 protein, human; D002868:Chromosomal Proteins, Non-Histone; D051034:Inhibitor of Apoptosis Proteins; D008869:Microtubule-Associated Proteins; D009363:Neoplasm Proteins; D012333:RNA, Messenger; D000077022:Survivin; D053504:Matrix Metalloproteinases, Membrane-Associated; D008666:Metalloendopeptidases; D020778:Matrix Metalloproteinase 2; D020780:Matrix Metalloproteinase 9